Abstract
Vascular endothelial growth factor (VEGF) is an angiogenic cytokine, which plays a major role in tumor angiogenesis. VEGF mRNA expression is controlled by hypoxia, growth factors and hormones through both transcriptional and post-transcriptional mechanisms. VEGF mRNA has a short half-life and its abundance is regulated by the binding of stabilizing (HuR, hRNP-L) and still uncharacterised destabilizing proteins to its 3′-untranslated region. Here, we report that the ACTH-regulated zinc-finger protein TIS11b and its homologs TIS11 and TIS11d interact with the 3′-untranslated region of VEGF mRNA and decrease its stability (half-life reduced from 130 to 60 min). Within the 2201 bp 3′-untranslated region of VEGF mRNA, we identified a 75 bp domain, containing two consensus AU-rich motifs, which binds TIS11b and mediates its destabilizing activity. Ribonucleoprotein (RNP) complex immunoprecipitation experiments allowed us to demonstrate that the interaction between TIS11b and VEGF 3′-untranslated region occurs in live cells. Knocking down TIS11b expression in primary adrenocortical cells with small interfering (si)RNAs clearly indicated that TIS11b participates in the control of both basal and, to a larger extent, ACTH-induced VEGF mRNA expression levels. TIS11b is the first VEGF mRNA-destabilizing protein identified so far and therefore appears as a new potential target in antiangiogenic therapies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- VEGF:
-
vascular endothelial growth factor
- TIS11:
-
TPA-induced sequence 11
- TTP:
-
tristetraprolin
- 3′-UTR:
-
3′-untranslated region
- ARE:
-
AU-rich element
- DRB:
-
5,6-dichloro-1-d-D-ribofuranosyl benzimidazole
- TNFα:
-
tumour necrosis factor α
- GM-CSF:
-
granulocyte macrophage colony-stimulating factor
- PVDF:
-
polyvinylidene fluoride
References
Ariyoshi N, Kim YC, Artemenko I, Bhattacharyya KK and Jefcoate CR . (1998). J. Biol. Chem., 273, 7610–7619.
Brand C, Cherradi N, Defaye G, Chinn A, Chambaz EM, Feige JJ and Bailly S . (1998). J. Biol. Chem., 273, 6410–6416.
Carballo E, Cao H, Lai WS, Kennington EA, Campbell D and Blackshear PJ . (2001). J. Biol. Chem., 276, 42580–42587.
Carballo E, Lai WS and Blackshear PJ . (1998). Science, 281, 1001–1005.
Carballo E, Lai WS and Blackshear PJ . (2000). Blood, 95, 1891–1899.
Chen CY and Shyu AB . (1995). Trends Biochem. Sci., 20, 465–470.
Chinn AM, Ciais D, Bailly S, Chambaz E, LaMarre J and Feige JJ . (2002). Mol. Endocrinol., 16, 1417–1427.
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T . (2001). Nature, 411, 494–498.
Ferrara N, Gerber HP and LeCouter J . (2003). Nat. Med., 9, 669–676.
Goldberg-Cohen I, Furneaux H and Levy AP . (2002). J. Biol. Chem., 277, 13635–13640.
Laemmli UK. (1970). Nature, 227, 680–685.
Lai WS, Kennington EA and Blackshear PJ . (2003). Mol. Cell. Biol., 23, 3798–3812.
Levy AP, Levy NS and Goldberg MA . (1996). J. Biol. Chem., 271, 2746–2753.
Levy NS, Chung S, Furneaux H and Levy AP . (1998). J. Biol. Chem., 273, 6417–6423.
Negoescu A, Labat-Moleur F, Brambilla E, Chambaz EM and Feige JJ . (1994). Mol. Cell. Endocrinol., 105, 155–163.
Niranjanakumari S, Lasda E, Brazas R and Garcia-Blanco MA . (2002). Methods, 26, 182–190.
Pages G, Berra E, Milanini J, Levy AP and Pouyssegur J . (2000). J. Biol. Chem., 275, 26484–26491.
Raghavan A, Robison RL, McNabb J, Miller CR, Williams DA and Bohjanen PR . (2001). J. Biol. Chem., 276, 47958–47965.
Ross HJ, Sato N, Ueyama Y and Koeffler HP . (1991). Blood, 77, 1787–1795.
Shih SC and Claffey KP . (1999). J. Biol. Chem., 274, 1359–1365.
Stoecklin G, Gross B, Ming XF and Moroni C . (2003). Oncogene, 22, 3554–3561.
Stoecklin G, Ming XF, Looser R and Moroni C . (2000). Mol. Cell. Biol., 20, 3753–3763.
Acknowledgements
We are indebted to Dr G Pages for providing us the pSp64-Sty plasmid. This work was supported by INSERM (EMI 01-05), University Joseph Fourier, CEA (DSV/DRDC/ANGIO), GEFLUC, Fondation pour la Recherche Médicale (grant to DC), and Association pour la Recherche sur le Cancer (project no 7626). We are indebted to the Ligue Nationale contre le Cancer for its financial support to DC (Doctoral grant, Comité de l'Isère) and NC (post-doctoral grant) and to INSERM for its support to JL (poste orange).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ciais, D., Cherradi, N., Bailly, S. et al. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene 23, 8673–8680 (2004). https://doi.org/10.1038/sj.onc.1207939
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207939
Keywords
This article is cited by
-
MicroRNA-377-3p exacerbates chronic obstructive pulmonary disease through suppressing ZFP36L1 expression and inducing lung fibroblast senescence
Respiratory Research (2024)
-
Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1
Nature Communications (2022)
-
Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis
Oncogene (2019)
-
Functional regulation of Zfp36l1 and Zfp36l2 in response to lipopolysaccharide in mouse RAW264.7 macrophages
Journal of Inflammation (2015)
-
ZFP36L1 promotes monocyte/macrophage differentiation by repressing CDK6
Scientific Reports (2015)